MoneyWorks4Me

Everest Organics informs about disclosure on related party transactions

18 Nov 2022 Evaluate

Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Everest Organics has informed that it enclosed the applicable disclosure on Related Party Transactions for the half year ended September 30, 2022 in the requisite format.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..